Reducing administrative burden is treated as a strategic lever to improve clinical throughput and patient care quality by ...

Employers use carve-outs and cash-pay channels to reduce GLP-1 costs, while Scripta’s Navigator helps members compare prices ...

Low-cost, scalable interventions can improve first-fill adherence, reduce avoidable hospitalizations, and support patient-centered strategies.

Shane Hochradel, COO of Health Solutions at Elevance Health, oversees operations to power Elevance Health’s partnership with care providers. Elevance Health's Shane Hochradel explains how the company ...

A prospective study of first-degree relatives of patients with MS found that this high-risk population faces significantly ...

“MASLD and T2DM represent intersecting global epidemics with substantial clinical and public health implications,” wrote the ...

Grinspoon noted that even incremental reductions in blood pressure incidence can translate into meaningful declines in ...

EMBRACE reported 12-month suppression rates of 94% (IV N6LS+CAB LA), 82% (SC), and 88% (oral SOC), with no virologic failures and no new clinically significant AEs after month 6. Presentations focused ...

Julie Rosenthal, MD, MS, discusses the future direction of research into treating age-related macular degeneration.

To bridge the gap between clinical exuberance and evidence-based practice, Todd Brown, MD, PhD, an endocrinologist and clinical investigator at Johns Hopkins University, sat down at the Conference on ...

Todd T. Brown, MD, PhD, serves as an endocrinologist and clinical investigator at Johns Hopkins Medical Center. At CROI 2026, experts weigh GLP‑1 drugs in HIV aging—titration tips, surgery precautions ...

Mitochondrial DNA heteroplasmy is independently associated with an increased risk of CLL, suggesting potential as a novel biomarker for early risk identification.